Sheets Smith Wealth Management increased its stake in Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,207 shares of the company’s stock after purchasing an additional 315 shares during the quarter. Sheets Smith Wealth Management’s holdings in Addus HomeCare were worth $669,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in ADUS. SG Americas Securities LLC purchased a new stake in Addus HomeCare in the third quarter worth approximately $532,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Addus HomeCare by 19.7% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,278 shares of the company’s stock worth $790,000 after purchasing an additional 1,528 shares during the last quarter. BluePath Capital Management LLC purchased a new position in shares of Addus HomeCare during the 3rd quarter worth $31,000. Advisor Partners II LLC purchased a new position in shares of Addus HomeCare during the 3rd quarter worth $237,000. Finally, Inspire Investing LLC boosted its stake in shares of Addus HomeCare by 6.1% during the 3rd quarter. Inspire Investing LLC now owns 3,600 shares of the company’s stock worth $307,000 after acquiring an additional 207 shares during the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.
Addus HomeCare Price Performance
NASDAQ ADUS traded down $0.04 on Monday, reaching $98.16. The company had a trading volume of 79,514 shares, compared to its average volume of 122,219. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18. The stock has a market capitalization of $1.61 billion, a PE ratio of 25.57, a price-to-earnings-growth ratio of 1.94 and a beta of 0.96. The firm’s 50 day moving average price is $98.27 and its 200 day moving average price is $92.33. Addus HomeCare Co. has a 12 month low of $78.35 and a 12 month high of $104.61.
Wall Street Analysts Forecast Growth
ADUS has been the topic of several analyst reports. Barclays cut shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price target on the stock. in a research note on Tuesday, April 23rd. Royal Bank of Canada reiterated an “outperform” rating and set a $102.00 price target on shares of Addus HomeCare in a research note on Thursday, February 29th. William Blair restated an “outperform” rating on shares of Addus HomeCare in a research note on Monday, February 5th. Finally, Oppenheimer restated an “outperform” rating and set a $118.00 target price on shares of Addus HomeCare in a research note on Tuesday, March 26th. One equities research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the stock. According to MarketBeat, Addus HomeCare presently has a consensus rating of “Moderate Buy” and a consensus target price of $103.00.
Read Our Latest Report on Addus HomeCare
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories
- Five stocks we like better than Addus HomeCare
- Why Invest in 5G? How to Invest in 5G Stocks
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- What is the Shanghai Stock Exchange Composite Index?
- 3 Value Stocks You Can Buy Before They Become Big
- 5 discounted opportunities for dividend growth investors
- Chinese Stocks Stage Impressive Rebound
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.